These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19924789)

  • 21. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
    Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
    Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
    Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular peripheral nerve sheath tumors: schwannoma, ancient schwannoma, and neurofibroma.
    Lee SK; Kim JY; Lee YS; Jeong HS
    Skeletal Radiol; 2020 Jun; 49(6):967-975. PubMed ID: 31932870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG-PET/CT for diagnosis of primary ovarian cancer.
    Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
    Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Imaging of Nerve Tumors.
    Behzad B; Dianat S
    Semin Musculoskelet Radiol; 2022 Apr; 26(2):172-181. PubMed ID: 35609578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
    Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC
    Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
    Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
    Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
    Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
    Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
    Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
    J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.
    Zhao L; Tong L; Lin J; Tang K; Zheng S; Li W; Cheng D; Yin W; Zheng X
    Eur Radiol; 2015 Jul; 25(7):1837-44. PubMed ID: 25636419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are preoperative complete blood count parameters in peripheral nerve sheath tumors useful diagnostic tools?
    Mısırlıoğlu M; Yapar A; Sezgin EA; Bulut EK; Beltir G; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):340-346. PubMed ID: 34145809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.
    Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR Neurography of Peripheral Nerve Tumors and Tumor-Mimics.
    Debs P; Fayad LM; Ahlawat S
    Semin Roentgenol; 2022 Jul; 57(3):232-240. PubMed ID: 35842244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.